CSI Market
Sign In | Register

Kestra Medical Technologies Ltd (KMTS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access KMTS Annual Cash Flow →
Cash flow data covering Kestra Medical Technologies Ltd–Apr 30 2025 offers a view into how Apr 30 2026's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
12 Months 		(Jan 31 2026) (Oct 31 2025) (Jul 31 2025) (Apr 30 2025)
Operating Activities
Income-131.61
Depreciation & amortization8.71
Amortization of Other Assets1.87
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-1.16
Share-based Compensation33.64
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-2.67
Non Cash Lease Expense0.27
Increase Decrease In Disposable Medical Equipment Supplies-0.47
Increase Decrease In Operating Lease Liability-0.54
Reserve For Lost Medical Supplies-
Provision For Uncollectible Accounts Receivable1.52
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable9.06
Increase (Decrease) in Accounts Payable4.30
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities8.20
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.56
Other Working Capital-0.04
Other Noncash Income (Expense)0.00
Other net0.11
Payments for (Proceeds from) Other Operating Activities-12.67
Discontinued operations0.00
Net Cash flow from Operating Activities-81.70
Investing Activities
Capital Expenditures-34.89
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.-163.04
Real Estate Investments0.00
Deposits For Medical Rental Equipment-0.53
Refund Of Deposits For Medical Rental Equipment0.18
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-5.76
Discontinued operations0.00
Net Cash Flow from Investing Activities-203.28
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock147.42
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.32
Deemed Dividend For Payments To Third Party On Behalf Of Stockholder-
Proceeds From Issuance Of Stock To Non Controlling Interest-
Payments Of Deferred Offering Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents237.93
Reconciliation Of Cash Cash Equivalents And Restricted Cash Abstact-
Purchases Of Property And Equipment In Accrued Liabilities Accounts Payable9.27
Capital Contribution From Parent To Settle Warrant Obligation-
Capital Expenditures Incurred But Not Yet Paid0.89
Payments Of Initial Public Offering Costs-
Deemed Dividend For Payments To Third Party On Behalf Of Shareholder-0.03
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities147.10
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-116.60
Total Cash Flow-137.89
4 historic quarters locked

Sign in to unlock the full Kestra Medical Technologies Ltd cash flow history.

Sign In Create Free Account

About Kestra Medical Technologies Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-111205

Figures are derived from filed reports and may be restated. Historical data is subject to revision.